AMG 176 exhibits robust antitumor activity in combination with standard of care agents in models of acute myeloid leukemia

被引：0
|
作者：
Caenepeel, Sean [1 ]
Belmontes, Brian [1 ]
Osgood, Tao [1 ]
Cajulis, Elaina [1 ]
Coxon, Angela [1 ]
Canon, Jude [1 ]
Hughes, Paul E. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-2180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2180
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cytotoxic activity of bortezomib alone and in combination with trail in human acute myeloid leukemia
    Conticello, C.
    Adamo, L.
    Vicari, L.
    Giuffrida, R.
    Iannolo, G.
    Palumbo, G. A.
    Anastasi, G.
    Caruso, L.
    Moschetti, G.
    Cupri, A.
    Gulisano, M.
    De Maria, R.
    Giustolisi, R.
    Di Raimondo, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 52 - 53
  • [32] Combined inhibition of MCL1 and BCL-2 with AMG 176 and venetoclax induces anti-tumor effects in primary patient samples and models of acute myeloid leukemia
    Caenepeel, Sean R.
    Osgood, Tao
    Belmontes, Brian
    Sun, Jan
    Cajulis, Elaina
    Wei, Andrew
    Coxon, Angela
    Canon, Jude
    Hughes, Paul
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Pediatric Preclinical Testing Consortium Evaluation of the MCL1 Inhibitor, AMG 176, Against Xenograft Models of Acute Lymphoblastic Leukemia
    Lock, Richard B.
    Evans, Kathryn
    Watts, Ben
    Randall, Joanna
    Toscan, Cara E.
    Earley, Eric J.
    Erickson, Stephen W.
    Belmontes, Brian
    Wong, Philip
    Teicher, Beverly A.
    Hughes, Paul E.
    Smith, Malcolm A.
    BLOOD, 2022, 140 : 11690 - 11691
  • [34] The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study
    Xin, Fei
    Yu, Yan-Hui
    Shen, Xu-Liang
    Zhang, Guo-Xiang
    HEMATOLOGY, 2024, 29 (01)
  • [35] Synergistic Combination Activity of the Novel GSPT1 Degrader CC-90009 in Acute Myeloid Leukemia Models
    Pierce, Daniel W.
    Yao, Tsun-Wen Sheena
    Yao, Sheena
    Pace, Emily
    Wang, Hongbin
    Flandin-Blety, Pierre
    Benitez, Alicia
    Guarinos, Carla
    Hoffmann, Matthew
    Carrancio, Soraya
    Fan, Jonhong
    Pourdehnad, Michael
    BLOOD, 2021, 138
  • [36] Antitumor activity of AMG 706 alone and in combination with chemotherapy against established human tumor xenograft models in nude mice
    Starnes, Charlie O.
    Coxon, Angela
    Scully, Sheila
    Freeman, Dan
    Patel, Vinod
    Tasker, Andrew
    Polverino, Tony
    Kendall, Rick
    Radinsky, Robert
    CANCER RESEARCH, 2006, 66 (08)
  • [37] Intensifying induction therapy in acute myeloid leukemia: Has a new standard of care emerged?
    Rowe, JM
    Tallman, MS
    BLOOD, 1997, 90 (06) : 2121 - 2126
  • [38] A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
    Saland, E.
    Boutzen, H.
    Castellano, R.
    Pouyet, L.
    Griessinger, E.
    Larrue, C.
    de Toni, F.
    Scotland, S.
    David, M.
    Danet-Desnoyers, G.
    Vergez, F.
    Barreira, Y.
    Collette, Y.
    Recher, C.
    Sarry, J-E
    BLOOD CANCER JOURNAL, 2015, 5 : e297 - e297
  • [39] A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
    E Saland
    H Boutzen
    R Castellano
    L Pouyet
    E Griessinger
    C Larrue
    F de Toni
    S Scotland
    M David
    G Danet-Desnoyers
    F Vergez
    Y Barreira
    Y Collette
    C Récher
    J-E Sarry
    Blood Cancer Journal, 2015, 5 : e297 - e297
  • [40] Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
    Graveno, Molly E.
    Carulli, Alison
    Freyer, Craig W.
    Mangan, Brendan L.
    Nietupski, Robert
    Loren, Alison W.
    Frey, Noelle, V
    Porter, David L.
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Babushok, Daria, V
    Pratz, Keith W.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1645 - 1650
12345